Depomed, Inc. (NASDAQ: DEPO), a specialty pharmaceutical company, is devoted to enhancing existing pharmaceutical products. To date, the company has brought two products to market and has developed a pipeline with late-stage product opportunities designed to address common medical conditions. Depomed’s core delivery technology, AcuForm, is a patented, polymer-based technology that improves delivery through gastric retention. For further information, visit the Company’s web site at www.depomedinc.com.
- 17 years ago
QualityStocks
Depomed, Inc. (NASDAQ: DEPO)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Ramps Up Innovation, Logistics to Power Growth
Massimo (NASDAQ: MAMO) is making strategic moves to actively enhance its position in the powersports and…
-
QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Unveils Significant Resource Estimate at Storm Copper Project
Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a mineral exploration company focused on high-grade metals deposits,…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Expands Portfolio with Additional Solar Project in Upstate New York
SolarBank is developing a 4.584 MW DC ground-mount solar project in upstate New York, projected…